Assist. Prof. Dr. Chun-Feng Huang, En Chu Kong Hospital/National Yang Ming Chiao Tung University, Taiwan
Assist. Prof. Dr. Chun-Feng Huang, MD, Ph.D. is an Assistant Professor at the School of Medicine, National Yang Ming Chiao Tung University, and Chief of the Department of Family Medicine at En Chu Kong Hospital, Taiwan. He holds an MD from National Yang Ming Chiao Tung University and a Ph.D. from Taipei Medical University. Certified in clinical densitometry, family medicine, and integrative medicine, his research focuses on metabolomics, precision medicine, gerontology, and osteoporosis. Dr. Huang has received numerous awards, including first prizes from the Taiwan Association of Family Medicine, and serves as a leader in medical organizations promoting healthcare and osteoporosis care. šš¬
Publication Profile
Google Scholar
Educational Background
Assist. Prof. Dr. Chun-Feng Huang has an impressive academic foundation in medicine and clinical research. He earned his Doctor of Medicine (MD) from the prestigious National Yang Ming Chiao Tung University, School of Medicine, Taiwan š©ŗ. Further advancing his expertise, he completed a Ph.D. at Taipei Medical Universityās Graduate Institute of Clinical Medicine, Taiwan š¬. His education reflects a strong commitment to advancing healthcare through rigorous training and research. Dr. Huangās academic journey has been pivotal in shaping his contributions to family medicine, precision healthcare, and osteoporosis studies. š
Certifications
Assist. Prof. Dr. Chun-Feng Huang holds prestigious certifications that showcase his expertise across multiple disciplines in healthcare. He is a Certified Clinical Densitometrist accredited by the International Society for Clinical Densitometry (ISCD) š¦“š. Additionally, he is Board Certified in Family Medicine, Hospice and Palliative Medicine, Integrative Medicine, and Osteoporosis š©ŗšæ. These certifications highlight his dedication to providing comprehensive patient care, particularly in managing chronic conditions, end-of-life care, and bone health. Dr. Huangās advanced qualifications establish him as a leader in delivering holistic and evidence-based medical practices. š
Assist. Prof. Dr. Chun-Feng Huang has earned numerous awards and distinctions for his impactful contributions to healthcare. As Principal Investigator for the Mountain and Offshore Healthcare Plan (2010ā2015) šļøš„ and healthcare services in correctional institutions (2013ā2015) šļøš¬, he improved medical accessibility in Yilan County. He served as Chairman of the Yilan County Kang Tai Community Development Association (2014ā2016) and Director of the Taipei Smart City IoT Association (2015ā2017) šš”. Dr. Huang also received the First Prize at the Taiwan Association of Family Medicineās Annual Academic Conference (2011, 2018) š
š. Currently, he reviews for Taiwanās Food and Drug Administration. šāļø
Research Interests
Assist. Prof. Dr. Chun-Feng Huang focuses on advancing medical science through diverse research interests. His work in metabolomics šš§Ŗ aims to unravel complex biochemical processes, while his contributions to precision medicine šÆš§¬ strive for personalized healthcare solutions. With a strong emphasis on gerontology š“šµ, he explores aging and elderly care, addressing their unique health needs. Additionally, his research on osteoporosis š¦“š seeks to improve bone health and preventive strategies. Dr. Huangās innovative approach integrates technology and science, aiming to enhance healthcare outcomes for diverse populations. šš”
Publication Top Notes
- Nicotinuric acid: a potential marker of metabolic syndrome through a metabolomics-based approach (Diabetes Care, 2013) ā Cited by: 57 š©ŗš§¬
- Effects of incorporating multidomain interventions into integrated primary care on quality of life: a randomized controlled trial (The Lancet Healthy Longevity, 2021) ā Cited by: 55 šš
- Heat stress responses modulate calcium regulations and electrophysiological characteristics in atrial myocytes (Journal of Molecular and Cellular Cardiology, 2010) ā Cited by: 38 šš„
- Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update (Journal of the Formosan Medical Association, 2023) ā Cited by: 29 š¦“š
- Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality (Bone, 2022) ā Cited by: 24 š„šŖ
- Mononucleated and binucleated cardiomyocytes in left atrium and pulmonary vein have different electrical activity and calcium dynamics (Progress in Biophysics and Molecular Biology, 2012) ā Cited by: 22 ā”š©¹
- Pharmacologic intervention for prevention of fractures in osteopenic and osteoporotic postmenopausal women (Bone Reports, 2020) ā Cited by: 19 šš©āāļø
- Retrospective study of the effects of zoledronic acid on muscle mass in osteoporosis patients (Drug Design, Development and Therapy, 2021) ā Cited by: 17 šŖš¦“
- Detection of ventilatory thresholds using near-infrared spectroscopy (Saudi Journal of Biological Sciences, 2020) ā Cited by: 15 š«š¬
- First insights on value-based healthcare of elders using ICHOM older person standard set reporting (BMC Geriatrics, 2020) ā Cited by: 14 š“š